Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $32.49M+44.5% | $22.49M-55.8% | $50.87M+27.9% | $39.78M-12.7% | $45.56M-7.9% | ||
| $7K— | —— | $7K+16.7% | $6K-14.3% | $7K+16.7% | ||
| $10.62M+6.5% | $9.97M-9.1% | $10.97M-4.2% | $11.46M-8.4% | $12.5M+24.1% | ||
| $27.76M-78.0% | $126.15M+16.0% | $108.73M+37.1% | $79.33M+133% | $33.99M-55.0% | ||
| —— | $107K+50.7% | $71K+1,675% | $4K-96.9% | $128K-75.0% | ||
| -$183.65M-941% | -$17.63M-268% | -$4.79M+75.6% | -$19.59M-929% | $2.36M+133% | ||
| $5M0.0% | $5M+33.3% | $3.75M0.0% | $3.75M0.0% | $3.75M0.0% | ||
| -$7.22M-139% | -$3.02M-0.6% | -$3M-11.5% | -$2.69M-663% | -$352K+87.2% | ||
| -$163.1M-255% | $105.5M+4.5% | $100.95M+76.9% | $57.05M+58.5% | $36M-45.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.